CoChat
Sign Up
Cited by 61

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Combinatorial Control of Suicide Gene Expression by Tissue-specific Promoter and microRNA Regulation for Cancer Therapy

Wu, Chunxiao, Lin, Jiakai, Hong, Michelle, Choudhury, Yukti, Balani, Poonam, Leung, Doreen, Dang, Lam H, Zhao, Ying, Zeng, Jieming, Wang, Shu·2009·Molecular Therapy
DOI 10.1038/mt.2009.225
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mt.2009.225

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. Harrington, 2000, Transcriptional control: an essential component of cancer gene therapy strategies, Adv Drug Deliv Rev, 44, 167, 10.1016/S0169-409X(00)00093-4 · DOI
  2. Robson, 2003, Transcriptional targeting in cancer gene therapy, J Biomed Biotechnol, 2003, 110, 10.1155/S1110724303209074 · DOI
  3. Saukkonen, 2004, Tissue-specific promoters for cancer gene therapy, Expert Opin Biol Ther, 4, 683, 10.1517/14712598.4.5.683 · DOI
  4. Yang, 2005, Gene expression evolves faster in narrowly than in broadly expressed mammalian genes, Mol Biol Evol, 22, 2113, 10.1093/molbev/msi206 · DOI
  5. Birney, 2007, Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project, Nature, 447, 799, 10.1038/nature05874 · DOI · Paper page
  6. Stoff-Khalili, 2008, Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control, Breast Cancer Res Treat, 108, 43, 10.1007/s10549-007-9587-7 · DOI
  7. Filipowicz, 2008, Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight, Nat Rev Genet, 9, 102, 10.1038/nrg2290 · DOI
  8. John, 2004, Human MicroRNA targets, PLoS Biol, 2, e363, 10.1371/journal.pbio.0020363 · DOI · Paper page
  9. Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15, 10.1016/j.cell.2004.12.035 · DOI · Paper page
  10. Brown, 2007, Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state, Nat Biotechnol, 25, 1457, 10.1038/nbt1372 · DOI
  11. Ciafrè, 2005, Extensive modulation of a set of microRNAs in primary glioblastoma, Biochem Biophys Res Commun, 334, 1351, 10.1016/j.bbrc.2005.07.030 · DOI · Paper page
  12. Saito, 2006, Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells, Cancer Cell, 9, 435, 10.1016/j.ccr.2006.04.020 · DOI
  13. Wang, 2006, Astrocytic expression of transgene in the rat brain mediated by baculovirus vectors containing an astrocyte-specific promoter, Gene Ther, 13, 1447, 10.1038/sj.gt.3302771 · DOI
  14. Wang, 2006, Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy, Cancer Res, 66, 5798, 10.1158/0008-5472.CAN-05-4514 · DOI
  15. Griffiths-Jones, 2008, miRBase: tools for microRNA genomics, Nucleic Acids Res, 36, D154, 10.1093/nar/gkm952 · DOI
  16. Chen, 1998, A glial-specific, repressible, adenovirus vector for brain tumor gene therapy, Cancer Res, 58, 3504
  17. McKie, 1998, Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector—potential glioblastoma targeting, Gene Ther, 5, 440, 10.1038/sj.gt.3300621 · DOI
  18. Horst, 2007, Targeting malignant gliomas with a glial fibrillary acidic protein (GFAP)-selective oncolytic adenovirus, J Gene Med, 9, 1071, 10.1002/jgm.1110 · DOI
  19. Herraiz, 2003, Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion, Hum Gene Ther, 14, 463, 10.1089/104303403321467225 · DOI
  20. van der Eb, 2003, Ganciclovir nucleotides accumulate in mitochondria of rat liver cells expressing the herpes simplex virus thymidine kinase gene, J Gene Med, 5, 1018, 10.1002/jgm.450 · DOI
  21. Maron, 1997, Differential toxicity of ganciclovir for rat neurons and astrocytes in primary culture following adenovirus-mediated transfer of the HSVtk gene, Gene Ther, 4, 25, 10.1038/sj.gt.3300353 · DOI
  22. Bush, 1998, Fulminant jejuno-ileitis following ablation of enteric glia in adult transgenic mice, Cell, 93, 189, 10.1016/S0092-8674(00)81571-8 · DOI
  23. Bushati, 2007, microRNA functions, Annu Rev Cell Dev Biol, 23, 175, 10.1146/annurev.cellbio.23.090506.123406 · DOI · Paper page
  24. Kloosterman, 2006, The diverse functions of microRNAs in animal development and disease, Dev Cell, 11, 441, 10.1016/j.devcel.2006.09.009 · DOI · Paper page
  25. Esquela-Kerscher, 2006, Oncomirs—microRNAs with a role in cancer, Nat Rev Cancer, 6, 259, 10.1038/nrc1840 · DOI · Paper page
  26. Rosenfeld, 2008, MicroRNAs accurately identify cancer tissue origin, Nat Biotechnol, 26, 462, 10.1038/nbt1392 · DOI · Paper page
  27. Calin, 2004, Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers, Proc Natl Acad Sci USA, 101, 2999, 10.1073/pnas.0307323101 · DOI
  28. Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702 · DOI
  29. Silber, 2008, miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells, BMC Med, 6, 14, 10.1186/1741-7015-6-14 · DOI · Paper page
  30. Godlewski, 2008, Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal, Cancer Res, 68, 9125, 10.1158/0008-5472.CAN-08-2629 · DOI · Paper page
  31. Bartel, 2004, Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs, Nat Rev Genet, 5, 396, 10.1038/nrg1328 · DOI
  32. Reinhart, 2000, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans, Nature, 403, 901, 10.1038/35002607 · DOI
  33. Abrahante, 2003, The Caenorhabditis elegans hunchback-like gene lin-57/hbl-1 controls developmental time and is regulated by microRNAs, Dev Cell, 4, 625, 10.1016/S1534-5807(03)00127-8 · DOI
  34. Lin, 2003, The C elegans hunchback homolog, hbl-1, controls temporal patterning and is a probable microRNA target, Dev Cell, 4, 639, 10.1016/S1534-5807(03)00124-2 · DOI
  35. Doench, 2003, siRNAs can function as miRNAs, Genes Dev, 17, 438, 10.1101/gad.1064703 · DOI
  36. Zeng, 2007, Baculoviral vector-mediated transient and stable transgene expression in human embryonic stem cells, Stem Cells, 25, 1055, 10.1634/stemcells.2006-0616 · DOI
  37. Griffiths-Jones, 2006, miRBase: microRNA sequences, targets and gene nomenclature, Nucleic Acids Res, 34, D140, 10.1093/nar/gkj112 · DOI · Paper page
  38. Shi, 2005, Facile means for quantifying microRNA expression by real-time PCR, BioTechniques, 39, 519, 10.2144/000112010 · DOI
  39. Balani, 2009, High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment, Mol Ther, 17, 1003, 10.1038/mt.2009.22 · DOI

Cited by

Sorted by citations

See all 61

Metadata

Authors
Wu, C., Lin, J., Hong, M., Choudhury, Y., Balani, P., Leung, D., Dang, L. H., Zhao, Y., Zeng, J., & Wang, S.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2009-12
Volume
17
Issue
12
Pages
2058-2066
ISSN
1525-0016
DOI
10.1038/mt.2009.225
Cited by
61
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review